Imicarb is a potent antiprotozoal medication, belonging to the carbanilide derivative class. It operates by disrupting nucleic acids in the DNA of susceptible organisms, hindering cellular repair and replication. Used widely in veterinary medicine, Imicarb effectively treats and prevents bovine babesiosis (Redwater fever) in cattle. It is also essential for managing babesiosis in dogs and anaplasmosis in horses and sheep. Imicarb stands as a crucial solution against protozoal infections in various animal species.